Related Experiment Video
Updated: Jan 29, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
(Not Giving Up) The Marathon Race of MET Targeting Therapy: Are We There Yet?
Patrick C Ma1,2
1WVU Cancer Institute, WVU Medicine, West Virginia University, Morgantown, West Virginia. pcma@hsc.wvu.edu.
Abstract:
Among the various MET aberrations, MET amplification and METex14 have emerged as valid predictive biomarkers for MET inhibition. Despite challenges that have limited the development of MET inhibitors, we can learn from the latest efforts in biomarker-based therapy to better identify the patients who will benefit from treatment with these agents.See related articles by Hong et al., p. 2403 and Van Cutsem et al., p. 2414.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
RACE - Rapid Amplification of cDNA Ends
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

